RxDoctor Payments Data

Kayla Batchelor, DO

Family Medicine · Moultrie, GANPI 1760968267

Payments from drug & device makers

$472in general payments, 2019–2025

Across 24 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$164
  • AbbVie$81
  • Pfizer$60
  • Gilead$60
  • Inspire Medical Systems, Inc.$48
  • Lilly USA, LLC$48
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$452100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$472 in reported general payments places this provider in the 45th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$33,151
Medicare patients
166
Services billed
577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide67$73,763
EliquisApixaban58$60,687
OzempicSemaglutide56$58,095
FarxigaDapagliflozin Propanediol30$28,940
LinzessLinaclotide31$27,875
JanuviaSitagliptin Phosphate23$25,126
XareltoRivaroxaban31$22,742
TrulicityDulaglutide17$16,887
JardianceEmpagliflozin24$14,693
Repatha SureclickEvolocumab18$9,734
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$8,970
GemtesaVibegron13$5,947
SymbicortBudesonide/Formoterol Fumarate22$5,609
ArexvyRsvpref3 Antigen/As01e/Pf11$3,425
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$3,025

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$48$90,64984 claims
PfizerEliquis$60$60,68758 claims
AbbVieLinzess$81$27,87531 claims
Johnson & JohnsonXarelto$164$22,74231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Moultrie

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →